In contrast, we found that SMO inhibition sensitized cholangiocarcinoma cells to TRAIL even after depletion of Bid, Bim, Bax, or Bak by specific siRNA, suggesting mitochondrial dysfunction is not required for TRAIL killing in this model. This evidence concerns the gene TNFSF10 and cholangiocarcinoma.